| Nothing at stake in knowledge D Rose, E Machery, S Stich, M Alai, A Angelucci, R Berniūnas, EE Buchtel, ... Noûs 53 (1), 224-247, 2019 | 105 | 2019 |
| Epistemology of causal inference in pharmacology: Towards a framework for the assessment of harms J Landes, B Osimani, R Poellinger European Journal for Philosophy of Science 8 (1), 3-49, 2018 | 65 | 2018 |
| The gettier intuition from South America to Asia E Machery, S Stich, D Rose, M Alai, A Angelucci, R Berniūnas, EE Buchtel, ... Journal of Indian Council of Philosophical Research 34, 517-541, 2017 | 60 | 2017 |
| For whom does determinism undermine moral responsibility? Surveying the conditions for free will across cultures IR Hannikainen, E Machery, D Rose, S Stich, CY Olivola, P Sousa, ... Frontiers in psychology 10, 2428, 2019 | 48 | 2019 |
| Until RCT proven? On the asymmetry of evidence requirements for risk assessment B Osimani Journal of evaluation in clinical practice 19 (3), 454-462, 2013 | 38 | 2013 |
| Hunting side effects and explaining them: should we reverse evidence hierarchies upside down? B Osimani Topoi 33 (2), 295-312, 2014 | 32 | 2014 |
| The precautionary principle in the pharmaceutical domain: a philosophical enquiry into probabilistic reasoning and risk aversion B Osimani Health, risk & society 15 (2), 123-143, 2013 | 32 | 2013 |
| De Pulchritudine non est Disputandum? A cross‐cultural investigation of the alleged intersubjective validity of aesthetic judgment F Cova, CY Olivola, E Machery, S Stich, D Rose, M Alai, A Angelucci, ... Mind & Language 34 (3), 317-338, 2019 | 26 | 2019 |
| Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms? B Osimani, F Mignini Drug safety 38, 1-11, 2015 | 25 | 2015 |
| The ship of Theseus puzzle D Rose, E Machery, S Stich, M Alai, A Angelucci, R Berniūnas, EE Buchtel, ... Oxford studies in experimental philosophy 3, 158-174, 2020 | 22 | 2020 |
| E-synthesis: a Bayesian framework for causal assessment in pharmacosurveillance F De Pretis, J Landes, B Osimani Frontiers in Pharmacology 10, 1317, 2019 | 22 | 2019 |
| Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management B Osimani Health, Risk & Society 12 (5), 453-469, 2010 | 21 | 2010 |
| Reviewing the mechanistic evidence assessors E-synthesis and EBM+: a case study of amoxicillin and drug reaction with eosinophilia and systemic symptoms (DRESS) AY Abdin, D Auker-Howlett, J Landes, G Mulla, C Jacob, B Osimani Current Pharmaceutical Design 25 (16), 1866-1880, 2019 | 19 | 2019 |
| New Insights in Computational Methods for Pharmacovigilance: E-Synthesis, a Bayesian Framework for Causal Assessment F De Pretis, B Osimani International journal of environmental research and public health 16 (12), 2221, 2019 | 12 | 2019 |
| An epistemic analysis of the precautionary principle B Osimani Dilemata: International Journal of Applied Ethics, 149-167, 2013 | 12 | 2013 |
| Disability, human rights, and the International Classification of Functioning, Disability, and Health: systematic review M Aluas, E Colombetti, B Osimani, A Musio, A Pessina American Journal of Physical Medicine & Rehabilitation 91 (13), S146-S154, 2012 | 12 | 2012 |
| Probabilistic information and decision making in the health context: the package leaflet as basis for informed consent B Osimani, E Rigotti PhD Thesis, University of Lugano, 2007 | 12 | 2007 |
| Varieties of error and varieties of evidence in scientific inference B Osimani, J Landes The British Journal for the Philosophy of Science 74 (1), 117-170, 2023 | 11 | 2023 |
| Epistemic gains and epistemic games: Reliability and higher order evidence in medicine and pharmacology B Osimani Uncertainty in Pharmacology, 2020 | 11 | 2020 |
| Risk information processing and rational ignoring in the health context B Osimani The journal of socio-economics 41 (2), 169-179, 2012 | 11 | 2012 |
